 Multiagent chemotherapy relapsed acute lymphoblastic leukemia children Twenty-seven evaluable children early first bone marrow relapse acute lymphoblastic leukemia intensive induction/consolidation ongoing maintenance therapy Induction therapy course daunomycin vincristine prednisone teniposide cytosine arabinoside Ara-C L-asparaginase Intrathecal methotrexate hydrocortisone Ara-C induction/consolidation phase patients remission end induction/consolidation Maintenance drugs modified dosage schedule years small subgroup patients day day end induction/consolidation cumulative event-free survival EFS months months EFS patients day chemotherapy months months good reinduction remission duration rates months apparent plateau survival occurs months fall-off survival alive years